title: Managing peripherally inserted central catheter-related venous thrombosis: How I do it.
abstract: Imaging-guided insertion of central venous catheters, either in the form of a peripherally inserted central catheter (PICC) or through a subclavian or a jugular approach, is becoming the preferred method of acquiring long-term venous access for a variety of therapeutic purposes. The most significant complication from central venous catheters is thrombosis of the catheterized vein. Venous thrombosis related to the insertion of PICC lines is conventionally treated with line removal followed by anticoagulation. Direct thrombolysis with urokinase, using the lumen of the PICC line to facilitate the insertion of the infusion catheter is a simple, safe and effective treatment option. In this article, we describe our experience with this procedure and the technique used.
authors.affiliation: Radiology Department, Western Hospital, Melbourne, Victoria, Australia. ivan.chaitowitz@wh.org.au
authors.forename: I
authors.initials: I
authors.lastname: Chaitowitz
authors.forename: R
authors.initials: R
authors.lastname: Heng
authors.forename: K
authors.initials: K
authors.lastname: Bell
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002405:Catheterization, Central Venous / Q000009:adverse effects*; D003287:Contrast Media / Q000008:administration & dosage; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D015912:Thrombolytic Therapy / Q000295:instrumentation* / Q000379:methods*; D016896:Treatment Outcome; D014568:Urokinase-Type Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use; D020246:Venous Thrombosis / Q000188:drug therapy* / Q000209:etiology*
chemical_list: D003287:Contrast Media; D005343:Fibrinolytic Agents; D014568:Urokinase-Type Plasminogen Activator